Mineralys Therapeutics Execs Buy Low, Sell High: CMO’s 10‑b‑5‑1 Trades Signal Confidence Amid Volatile Stock
Mineralys insider trading shows execs buying low, selling high—hinting a possible undervaluation amid volatile, clinical‑stage risks.
3 minutes to read